Intech Investment Management LLC Has $7.70 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Intech Investment Management LLC reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 23.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 101,922 shares of the company’s stock after selling 31,531 shares during the quarter. Intech Investment Management LLC owned about 0.08% of Henry Schein worth $7,697,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of HSIC. Arizona State Retirement System lifted its position in Henry Schein by 0.4% during the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after purchasing an additional 149 shares during the period. Empirical Finance LLC grew its holdings in Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after acquiring an additional 160 shares during the period. Keene & Associates Inc. raised its position in shares of Henry Schein by 4.0% during the 1st quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock valued at $340,000 after acquiring an additional 175 shares during the last quarter. Wahed Invest LLC lifted its stake in shares of Henry Schein by 9.2% in the 4th quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock valued at $168,000 after purchasing an additional 187 shares during the period. Finally, Crossmark Global Holdings Inc. boosted its position in shares of Henry Schein by 1.5% in the 4th quarter. Crossmark Global Holdings Inc. now owns 13,090 shares of the company’s stock worth $991,000 after purchasing an additional 197 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Down 0.5 %

HSIC traded down $0.33 during trading on Friday, hitting $70.34. The company had a trading volume of 1,515,830 shares, compared to its average volume of 1,169,957. The company has a market capitalization of $9.01 billion, a PE ratio of 23.76, a PEG ratio of 1.74 and a beta of 0.87. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The firm’s 50-day moving average price is $68.38 and its 200 day moving average price is $71.99.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.09. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the business posted $1.21 EPS. As a group, equities analysts expect that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

HSIC has been the topic of several analyst reports. UBS Group cut their target price on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. Barrington Research reissued an “outperform” rating and set a $92.00 price objective on shares of Henry Schein in a research note on Friday, July 5th. Piper Sandler restated an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. Finally, Evercore ISI cut their target price on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Henry Schein has an average rating of “Hold” and a consensus price target of $80.73.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.